Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olena Molokanova is active.

Publication


Featured researches published by Olena Molokanova.


Nature Nanotechnology | 2009

Mechanically interlocked calix[4]arene dimers display reversible bond breakage under force

Matthias Janke; Yuliya Rudzevich; Olena Molokanova; Thorsten Metzroth; Ingo Mey; Gregor Diezemann; Piotr E. Marszalek; Jürgen Gauss; Volker Böhmer; Andreas Janshoff

The physics of nanoscopic systems is strongly governed by thermal fluctuations that produce significant deviations from the behaviour of large ensembles. Stretching experiments of single molecules offer a unique way to study fundamental theories of statistical mechanics, as recently shown for the unzipping of RNA hairpins. Here, we report a molecular design based on oligo calix[4]arene catenanes-calixarene dimers held together by 16 hydrogen bridges-in which loops within the molecules limit how far the calixarene nanocapsules can be separated. This mechanically locked structure tunes the energy landscape of dimers, thus permitting the reversible rupture and rejoining of the individual nanocapsules. Experimental evidence, supported by molecular dynamics simulations, reveals the presence of an intermediate state involving the concerted rupture of the 16 hydrogen bridges. Stochastic modelling using a three-well potential under external load allows reconstruction of the energy landscape.


Matrix Biology | 2017

Inducible knockdown of procollagen I protects mice from liver fibrosis and leads to dysregulated matrix genes and attenuated inflammation

Olena Molokanova; Kai Schönig; S.-Y. Weng; X.-Y. Wang; Matthias Bros; Mustafa Diken; Svetlana Ohngemach; Morten A. Karsdal; Dennis Strand; Alexei Nikolaev; Leonid Eshkind; Detlef Schuppan

Organ fibrosis is characterized by a chronic wound-healing response, with excess deposition of extracellular matrix components. Here, collagen type I represents the most abundant scar component and a primary target for antifibrotic therapies. Liver fibrosis can progress to cirrhosis and primary liver cancer, which are the major causes of liver related morbidity and mortality. However, a (pro-)collagen type I specific therapy remains difficult and its therapeutic abrogation may incur unwanted side effects. We therefore designed tetracycline-regulated procollagen alpha1(I) short hairpin (sh)RNA expressing mice that permit a highly efficient inducible knockdown of the procollagen alpha1(I) gene in activated (myo-)fibroblasts, to study the effect of induced procollagen type I deficiency. Transgenic mice were generated using recombinase-mediated integration in embryonic stem cells or zinc-finger nuclease-aided genomic targeting combined with miR30-shRNA technology. Liver fibrosis was induced in transgenic mice by carbon tetrachloride, either without or with doxycycline supplementation. Doxycycline treated mice showed an 80-90% suppression of procollagen alpha1(I) transcription and a 40-50% reduction in hepatic collagen accumulation. Procollagen alpha1(I) knockdown also downregulated procollagens type III, IV and VI and other fibrosis related parameters. Moreover, this was associated with an attenuation of chronic inflammation, suggesting that collagen type I serves not only as major scar component, but also as modulator of other collagens and promoter of chronic inflammation.


EBioMedicine | 2018

IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal

S.-Y. Weng; X.-Y. Wang; Santosh Vijayan; Yilang Tang; Y.O. Kim; Kornelius Padberg; Tommy Regen; Olena Molokanova; Tao Chen; Tobias Bopp; Hansjörg Schild; Frank Brombacher; Jeff Crosby; Michael L. McCaleb; Ari Waisman; Ernesto Bockamp; Detlef Schuppan

Chronic hepatitis leads to liver fibrosis and cirrhosis. Cirrhosis is a major cause of worldwide morbidity and mortality. Macrophages play a key role in fibrosis progression and reversal. However, the signals that determine fibrogenic vs fibrolytic macrophage function remain ill defined. We studied the role of interleukin-4 receptor α (IL-4Rα), a potential central switch of macrophage polarization, in liver fibrosis progression and reversal. We demonstrate that inflammatory monocyte infiltration and liver fibrogenesis were suppressed in general IL-4Rα−/− as well as in macrophage-specific IL-4Rα−/− (IL-4RαΔLysM) mice. However, with deletion of IL-4RαΔLysM spontaneous fibrosis reversal was retarded. Results were replicated by pharmacological intervention using IL-4Rα-specific antisense oligonucleotides. Retarded resolution was linked to the loss of M2-type resident macrophages, which secreted MMP-12 through IL-4 and IL-13-mediated phospho-STAT6 activation. We conclude that IL-4Rα signaling regulates macrophage functional polarization in a context-dependent manner. Pharmacological targeting of macrophage polarization therefore requires disease stage-specific treatment strategies. Research in Context Alternative (M2-type) macrophage activation through IL-4Rα promotes liver inflammation and fibrosis progression but speeds up fibrosis reversal. This demonstrates context dependent, opposing roles of M2-type macrophages. During reversal IL-4Rα induces fibrolytic MMPs, especially MMP-12, through STAT6. Liver-specific antisense oligonucleotides efficiently block IL-4Rα expression and attenuate fibrosis progression.


Chemistry: A European Journal | 2007

Calix[4]arene‐Based Bis[2]catenanes: Synthesis and Chiral Resolution

Olena Molokanova; Anca Bogdan; Myroslav O. Vysotsky; Michael Bolte; Tomoyuki Ikai; Yoshio Okamoto; Volker Böhmer


Angewandte Chemie | 2006

Fourfold [2]Rotaxanes of Calix[4]arenes by Ring Closure

Olena Molokanova; Myroslav O. Vysotsky; Yudong Cao; Iris Thondorf; Volker Böhmer


Tetrahedron | 2009

Multiple catenanes based on tetraloop derivatives of calix[4]arenes

Olena Molokanova; Ganna Podoprygorina; Michael Bolte; Volker Böhmer


Angewandte Chemie | 2006

Vierfache [2]Rotaxane von Calix[4]arenen durch Ringschluss

Olena Molokanova; Myroslav O. Vysotsky; Yudong Cao; Iris Thondorf; Volker Böhmer


Journal of Hepatology | 2018

Inducible ablation of TGFß receptor type 2 limited to hepatic stellate cells potently inhibits liver fibrosis and attenuates inflamation

Olena Molokanova; Kai Schönig; S.-Y. Weng; X.-Y. Wang; S. Ohngemach; A. Nikolaev; Dennis Strand; L. Eshkind; Detlef Schuppan; S. Lorenz


Journal of Hepatology | 2017

Suppression of hepatic fibrosis by efficient Col1a1 silencing using shRNA inducible mouse models

Olena Molokanova; Kai Schönig; S.-Y. Weng; X.-Y. Wang; M. Bros; Mustafa Diken; S. Ohngemach; Morten A. Karsdal; A. Nikolaev; L. Eshkind; Detlef Schuppan


Journal of Hepatology | 2017

Glucagon-like peptide-1 receptor agonists ameliorate inflammation and fibrosis in an optimized rodent NASH model via inhibition of inflammatory macrophage activation

X.-Y. Wang; S.-Y. Weng; T. Chen; Olena Molokanova; J. Schattenberg; T. Klein; Detlef Schuppan

Collaboration


Dive into the Olena Molokanova's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge